nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.124	0.358	CbGbCtD
Fingolimod—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0606	0.175	CbGbCtD
Fingolimod—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0469	0.136	CbGbCtD
Fingolimod—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0436	0.126	CbGbCtD
Fingolimod—CYP4F2—tongue—peripheral nervous system neoplasm	0.0211	0.257	CbGeAlD
Fingolimod—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.02	0.058	CbGbCtD
Fingolimod—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0197	0.057	CbGbCtD
Fingolimod—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0184	0.0531	CbGbCtD
Fingolimod—S1PR1—ganglion—peripheral nervous system neoplasm	0.0167	0.203	CbGeAlD
Fingolimod—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0125	0.0362	CbGbCtD
Fingolimod—SPHK1—trigeminal ganglion—peripheral nervous system neoplasm	0.00811	0.0988	CbGeAlD
Fingolimod—CYP4F12—trigeminal ganglion—peripheral nervous system neoplasm	0.00779	0.0949	CbGeAlD
Fingolimod—CYP4F12—parotid gland—peripheral nervous system neoplasm	0.00735	0.0895	CbGeAlD
Fingolimod—S1PR1—brainstem—peripheral nervous system neoplasm	0.00726	0.0883	CbGeAlD
Fingolimod—S1PR5—cerebellum—peripheral nervous system neoplasm	0.00488	0.0594	CbGeAlD
Fingolimod—S1PR1—cerebellum—peripheral nervous system neoplasm	0.00358	0.0436	CbGeAlD
Fingolimod—CYP4F12—cerebellum—peripheral nervous system neoplasm	0.0034	0.0414	CbGeAlD
Fingolimod—SPHK1—Signaling by VEGF—PTPN11—peripheral nervous system neoplasm	0.00144	0.00674	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00137	0.00643	CbGpPWpGaD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—PTPN11—peripheral nervous system neoplasm	0.00135	0.0063	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00134	0.00626	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00132	0.00619	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00132	0.00619	CbGpPWpGaD
Fingolimod—S1PR1—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.00132	0.00618	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00132	0.00616	CbGpPWpGaD
Fingolimod—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00131	0.00611	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00127	0.00593	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00127	0.00593	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00122	0.0057	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.0012	0.00562	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00119	0.00559	CbGpPWpGaD
Fingolimod—S1PR1—Fc-epsilon receptor I signaling in mast cells—HRAS—peripheral nervous system neoplasm	0.00119	0.00556	CbGpPWpGaD
Fingolimod—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.00117	0.00325	CcSEcCtD
Fingolimod—Pneumonia—Vincristine—peripheral nervous system neoplasm	0.00116	0.00324	CcSEcCtD
Fingolimod—Cardiac arrest—Etoposide—peripheral nervous system neoplasm	0.00116	0.00322	CcSEcCtD
Fingolimod—Herpes zoster—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00322	CcSEcCtD
Fingolimod—Depression—Vincristine—peripheral nervous system neoplasm	0.00115	0.00322	CcSEcCtD
Fingolimod—S1PR3—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00115	0.00538	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00115	0.00538	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00115	0.00538	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00115	0.00536	CbGpPWpGaD
Fingolimod—Sinusitis—Alitretinoin—peripheral nervous system neoplasm	0.00113	0.00314	CcSEcCtD
Fingolimod—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.00112	0.00311	CcSEcCtD
Fingolimod—Liver injury—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00311	CcSEcCtD
Fingolimod—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.00111	0.00518	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.0011	0.00516	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.0011	0.00516	CbGpPWpGaD
Fingolimod—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.00109	0.00305	CcSEcCtD
Fingolimod—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.00109	0.00305	CcSEcCtD
Fingolimod—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.00109	0.00305	CcSEcCtD
Fingolimod—Cough—Topotecan—peripheral nervous system neoplasm	0.00109	0.00304	CcSEcCtD
Fingolimod—Cough—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.00301	CcSEcCtD
Fingolimod—Cough—Tretinoin—peripheral nervous system neoplasm	0.00108	0.00301	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Etoposide—peripheral nervous system neoplasm	0.00107	0.00299	CcSEcCtD
Fingolimod—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.00107	0.00298	CcSEcCtD
Fingolimod—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.00107	0.00298	CcSEcCtD
Fingolimod—Cough—Melphalan—peripheral nervous system neoplasm	0.00107	0.00297	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.00106	0.00294	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00105	0.00492	CbGpPWpGaD
Fingolimod—SPHK1—Fc-epsilon receptor I signaling in mast cells—HRAS—peripheral nervous system neoplasm	0.00105	0.00492	CbGpPWpGaD
Fingolimod—S1PR1—Fc-epsilon receptor I signaling in mast cells—AKT1—peripheral nervous system neoplasm	0.00105	0.00491	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.00105	0.00292	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.00105	0.00292	CcSEcCtD
Fingolimod—S1PR4—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00105	0.0049	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00104	0.00489	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.00103	0.00288	CcSEcCtD
Fingolimod—Liver injury—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00288	CcSEcCtD
Fingolimod—Alopecia—Dactinomycin—peripheral nervous system neoplasm	0.00103	0.00286	CcSEcCtD
Fingolimod—Connective tissue disorder—Vincristine—peripheral nervous system neoplasm	0.00102	0.00285	CcSEcCtD
Fingolimod—Infection—Topotecan—peripheral nervous system neoplasm	0.00101	0.00282	CcSEcCtD
Fingolimod—Eye disorder—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00281	CcSEcCtD
Fingolimod—S1PR5—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00101	0.00471	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00101	0.00471	CbGpPWpGaD
Fingolimod—Infection—Isotretinoin—peripheral nervous system neoplasm	0.001	0.0028	CcSEcCtD
Fingolimod—Infection—Tretinoin—peripheral nervous system neoplasm	0.001	0.0028	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.001	0.00469	CbGpPWpGaD
Fingolimod—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.000999	0.00278	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000997	0.00467	CbGpPWpGaD
Fingolimod—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.000991	0.00276	CcSEcCtD
Fingolimod—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.000991	0.00276	CcSEcCtD
Fingolimod—Infection—Melphalan—peripheral nervous system neoplasm	0.000991	0.00276	CcSEcCtD
Fingolimod—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.00099	0.00276	CcSEcCtD
Fingolimod—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000982	0.00274	CcSEcCtD
Fingolimod—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000982	0.00274	CcSEcCtD
Fingolimod—Angiopathy—Alitretinoin—peripheral nervous system neoplasm	0.000978	0.00273	CcSEcCtD
Fingolimod—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000969	0.0027	CcSEcCtD
Fingolimod—Atrioventricular block—Epirubicin—peripheral nervous system neoplasm	0.000968	0.0027	CcSEcCtD
Fingolimod—Cardiac disorder—Vincristine—peripheral nervous system neoplasm	0.000964	0.00269	CcSEcCtD
Fingolimod—S1PR5—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00096	0.00449	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00096	0.00449	CbGpPWpGaD
Fingolimod—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.000953	0.00265	CcSEcCtD
Fingolimod—Mental disorder—Alitretinoin—peripheral nervous system neoplasm	0.000945	0.00263	CcSEcCtD
Fingolimod—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.000944	0.00263	CcSEcCtD
Fingolimod—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.000944	0.00263	CcSEcCtD
Fingolimod—Pneumonia—Etoposide—peripheral nervous system neoplasm	0.000943	0.00263	CcSEcCtD
Fingolimod—Angiopathy—Vincristine—peripheral nervous system neoplasm	0.000943	0.00263	CcSEcCtD
Fingolimod—Infestation NOS—Etoposide—peripheral nervous system neoplasm	0.000937	0.00261	CcSEcCtD
Fingolimod—Infestation—Etoposide—peripheral nervous system neoplasm	0.000937	0.00261	CcSEcCtD
Fingolimod—Mediastinal disorder—Vincristine—peripheral nervous system neoplasm	0.000936	0.00261	CcSEcCtD
Fingolimod—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.000935	0.00261	CcSEcCtD
Fingolimod—Hypotension—Melphalan—peripheral nervous system neoplasm	0.000932	0.0026	CcSEcCtD
Fingolimod—SPHK1—Fc-epsilon receptor I signaling in mast cells—AKT1—peripheral nervous system neoplasm	0.000928	0.00434	CbGpPWpGaD
Fingolimod—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000921	0.0112	CbGeAlD
Fingolimod—Alopecia—Vincristine—peripheral nervous system neoplasm	0.000918	0.00256	CcSEcCtD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—NRAS—peripheral nervous system neoplasm	0.000916	0.00429	CbGpPWpGaD
Fingolimod—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.000915	0.00255	CcSEcCtD
Fingolimod—S1PR4—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000915	0.00428	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000914	0.00428	CbGpPWpGaD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—NRAS—peripheral nervous system neoplasm	0.000914	0.00428	CbGpPWpGaD
Fingolimod—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.00091	0.00254	CcSEcCtD
Fingolimod—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.000908	0.00253	CcSEcCtD
Fingolimod—Back pain—Alitretinoin—peripheral nervous system neoplasm	0.000908	0.00253	CcSEcCtD
Fingolimod—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.000908	0.00253	CcSEcCtD
Fingolimod—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.000908	0.00253	CcSEcCtD
Fingolimod—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.000906	0.00252	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000906	0.00424	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000903	0.00423	CbGpPWpGaD
Fingolimod—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.000903	0.00252	CcSEcCtD
Fingolimod—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.000901	0.00251	CcSEcCtD
Fingolimod—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.000901	0.00251	CcSEcCtD
Fingolimod—Atrioventricular block—Doxorubicin—peripheral nervous system neoplasm	0.000896	0.0025	CcSEcCtD
Fingolimod—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.000896	0.0025	CcSEcCtD
Fingolimod—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.000889	0.00248	CcSEcCtD
Fingolimod—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.000884	0.00246	CcSEcCtD
Fingolimod—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000884	0.00414	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000881	0.00412	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000881	0.00412	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—GNS—peripheral nervous system neoplasm	0.00088	0.00412	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00088	0.00245	CcSEcCtD
Fingolimod—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000878	0.00245	CcSEcCtD
Fingolimod—Back pain—Vincristine—peripheral nervous system neoplasm	0.000875	0.00244	CcSEcCtD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000874	0.00409	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000873	0.00243	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000873	0.00243	CcSEcCtD
Fingolimod—S1PR5—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000872	0.00408	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000872	0.00408	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000872	0.00408	CbGpPWpGaD
Fingolimod—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000871	0.00243	CcSEcCtD
Fingolimod—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000871	0.00243	CcSEcCtD
Fingolimod—SPHK1—Signaling by VEGF—NRAS—peripheral nervous system neoplasm	0.000865	0.00405	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000861	0.0024	CcSEcCtD
Fingolimod—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00086	0.0024	CcSEcCtD
Fingolimod—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.000858	0.00239	CcSEcCtD
Fingolimod—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.000853	0.00238	CcSEcCtD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—MYC—peripheral nervous system neoplasm	0.000852	0.00399	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—NME1—peripheral nervous system neoplasm	0.000844	0.00395	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000836	0.00391	CbGpPWpGaD
Fingolimod—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.000829	0.00231	CcSEcCtD
Fingolimod—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000828	0.00231	CcSEcCtD
Fingolimod—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000821	0.00229	CcSEcCtD
Fingolimod—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000819	0.00228	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—COX2—peripheral nervous system neoplasm	0.000813	0.0038	CbGpPWpGaD
Fingolimod—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.000812	0.00226	CcSEcCtD
Fingolimod—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00081	0.00226	CcSEcCtD
Fingolimod—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00081	0.00226	CcSEcCtD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—NRAS—peripheral nervous system neoplasm	0.000809	0.00379	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000804	0.00377	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000804	0.00377	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.0008	0.00374	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000794	0.00221	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000791	0.00371	CbGpPWpGaD
Fingolimod—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000786	0.00219	CcSEcCtD
Fingolimod—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000781	0.00218	CcSEcCtD
Fingolimod—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000781	0.00218	CcSEcCtD
Fingolimod—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000764	0.00213	CcSEcCtD
Fingolimod—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000761	0.00212	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—GNS—peripheral nervous system neoplasm	0.00076	0.00356	CbGpPWpGaD
Fingolimod—Eczema—Epirubicin—peripheral nervous system neoplasm	0.000759	0.00211	CcSEcCtD
Fingolimod—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000758	0.00211	CcSEcCtD
Fingolimod—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.000755	0.0021	CcSEcCtD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—MYC—peripheral nervous system neoplasm	0.000754	0.00353	CbGpPWpGaD
Fingolimod—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000754	0.0021	CcSEcCtD
Fingolimod—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000751	0.00209	CcSEcCtD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000751	0.00351	CbGpPWpGaD
Fingolimod—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000744	0.00207	CcSEcCtD
Fingolimod—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000744	0.00207	CcSEcCtD
Fingolimod—Infection—Vincristine—peripheral nervous system neoplasm	0.000733	0.00204	CcSEcCtD
Fingolimod—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000731	0.00204	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00073	0.00342	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—NME1—peripheral nervous system neoplasm	0.000729	0.00341	CbGpPWpGaD
Fingolimod—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000725	0.00202	CcSEcCtD
Fingolimod—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000725	0.00202	CcSEcCtD
Fingolimod—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000724	0.00202	CcSEcCtD
Fingolimod—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000721	0.00201	CcSEcCtD
Fingolimod—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000716	0.00199	CcSEcCtD
Fingolimod—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000716	0.00199	CcSEcCtD
Fingolimod—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000716	0.00199	CcSEcCtD
Fingolimod—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000715	0.00199	CcSEcCtD
Fingolimod—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000715	0.00199	CcSEcCtD
Fingolimod—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000714	0.00334	CbGpPWpGaD
Fingolimod—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000712	0.00198	CcSEcCtD
Fingolimod—Back pain—Etoposide—peripheral nervous system neoplasm	0.000709	0.00197	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000706	0.0033	CbGpPWpGaD
Fingolimod—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000706	0.00197	CcSEcCtD
Fingolimod—Eczema—Doxorubicin—peripheral nervous system neoplasm	0.000702	0.00196	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—COX2—peripheral nervous system neoplasm	0.000701	0.00328	CbGpPWpGaD
Fingolimod—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.000699	0.00195	CcSEcCtD
Fingolimod—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000697	0.00194	CcSEcCtD
Fingolimod—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	0.000696	0.00194	CcSEcCtD
Fingolimod—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000692	0.00193	CcSEcCtD
Fingolimod—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000692	0.00193	CcSEcCtD
Fingolimod—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00069	0.00192	CcSEcCtD
Fingolimod—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000688	0.00192	CcSEcCtD
Fingolimod—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000683	0.0019	CcSEcCtD
Fingolimod—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000683	0.0019	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000679	0.00318	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000679	0.00318	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000677	0.00317	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000676	0.00188	CcSEcCtD
Fingolimod—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000674	0.00188	CcSEcCtD
Fingolimod—Migraine—Epirubicin—peripheral nervous system neoplasm	0.000671	0.00187	CcSEcCtD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—HRAS—peripheral nervous system neoplasm	0.00067	0.00314	CbGpPWpGaD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—HRAS—peripheral nervous system neoplasm	0.000669	0.00313	CbGpPWpGaD
Fingolimod—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000668	0.00186	CcSEcCtD
Fingolimod—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000668	0.00186	CcSEcCtD
Fingolimod—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000663	0.00185	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000661	0.00184	CcSEcCtD
Fingolimod—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00066	0.00184	CcSEcCtD
Fingolimod—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000656	0.00183	CcSEcCtD
Fingolimod—SPHK1—Metabolism—GNS—peripheral nervous system neoplasm	0.000653	0.00306	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000651	0.00305	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000651	0.00305	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.000649	0.00304	CbGpPWpGaD
Fingolimod—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000648	0.00181	CcSEcCtD
Fingolimod—Infection—Cisplatin—peripheral nervous system neoplasm	0.000648	0.00181	CcSEcCtD
Fingolimod—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000644	0.00179	CcSEcCtD
Fingolimod—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00064	0.00178	CcSEcCtD
Fingolimod—Cough—Etoposide—peripheral nervous system neoplasm	0.000639	0.00178	CcSEcCtD
Fingolimod—Headache—Topotecan—peripheral nervous system neoplasm	0.000638	0.00178	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000637	0.00178	CcSEcCtD
Fingolimod—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000636	0.00177	CcSEcCtD
Fingolimod—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000634	0.00177	CcSEcCtD
Fingolimod—Headache—Tretinoin—peripheral nervous system neoplasm	0.000633	0.00176	CcSEcCtD
Fingolimod—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000633	0.00176	CcSEcCtD
Fingolimod—SPHK1—Signaling by VEGF—HRAS—peripheral nervous system neoplasm	0.000633	0.00296	CbGpPWpGaD
Fingolimod—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000632	0.00176	CcSEcCtD
Fingolimod—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.00063	0.00175	CcSEcCtD
Fingolimod—SPHK1—Metabolism—NME1—peripheral nervous system neoplasm	0.000626	0.00293	CbGpPWpGaD
Fingolimod—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000621	0.00173	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000619	0.00173	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000617	0.00289	CbGpPWpGaD
Fingolimod—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000614	0.00171	CcSEcCtD
Fingolimod—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00061	0.0017	CcSEcCtD
Fingolimod—SPHK1—Metabolism—COX2—peripheral nervous system neoplasm	0.000603	0.00282	CbGpPWpGaD
Fingolimod—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000601	0.00168	CcSEcCtD
Fingolimod—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.0006	0.00167	CcSEcCtD
Fingolimod—Infection—Etoposide—peripheral nervous system neoplasm	0.000594	0.00166	CcSEcCtD
Fingolimod—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000593	0.00165	CcSEcCtD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—HRAS—peripheral nervous system neoplasm	0.000592	0.00277	CbGpPWpGaD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—AKT1—peripheral nervous system neoplasm	0.000592	0.00277	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000591	0.00277	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000591	0.00277	CbGpPWpGaD
Fingolimod—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000589	0.00164	CcSEcCtD
Fingolimod—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000586	0.00163	CcSEcCtD
Fingolimod—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000583	0.00162	CcSEcCtD
Fingolimod—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000582	0.00162	CcSEcCtD
Fingolimod—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000581	0.00162	CcSEcCtD
Fingolimod—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.000574	0.00698	CbGeAlD
Fingolimod—S1PR3—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000569	0.00266	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000569	0.00266	CbGpPWpGaD
Fingolimod—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000568	0.00158	CcSEcCtD
Fingolimod—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000567	0.00158	CcSEcCtD
Fingolimod—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000565	0.00158	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000563	0.00157	CcSEcCtD
Fingolimod—SPHK1—Signaling by VEGF—AKT1—peripheral nervous system neoplasm	0.000559	0.00262	CbGpPWpGaD
Fingolimod—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000559	0.00156	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000556	0.00155	CcSEcCtD
Fingolimod—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00055	0.00153	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000546	0.00256	CbGpPWpGaD
Fingolimod—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000545	0.00152	CcSEcCtD
Fingolimod—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000542	0.00151	CcSEcCtD
Fingolimod—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000537	0.0015	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000537	0.00251	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000535	0.0025	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—ENO2—peripheral nervous system neoplasm	0.000533	0.0025	CbGpPWpGaD
Fingolimod—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000533	0.00149	CcSEcCtD
Fingolimod—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000533	0.00149	CcSEcCtD
Fingolimod—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00053	0.00148	CcSEcCtD
Fingolimod—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000529	0.00147	CcSEcCtD
Fingolimod—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000525	0.00146	CcSEcCtD
Fingolimod—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000525	0.00146	CcSEcCtD
Fingolimod—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000524	0.00146	CcSEcCtD
Fingolimod—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000524	0.00146	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000523	0.00245	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000517	0.00242	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000517	0.00242	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000517	0.00242	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000517	0.00242	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000516	0.00144	CcSEcCtD
Fingolimod—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000515	0.00144	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000515	0.00241	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000515	0.00241	CbGpPWpGaD
Fingolimod—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000507	0.00141	CcSEcCtD
Fingolimod—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000505	0.00141	CcSEcCtD
Fingolimod—S1PR3—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000498	0.00233	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000498	0.00233	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000494	0.00231	CbGpPWpGaD
Fingolimod—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000493	0.00137	CcSEcCtD
Fingolimod—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000493	0.00137	CcSEcCtD
Fingolimod—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000489	0.00136	CcSEcCtD
Fingolimod—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000488	0.00136	CcSEcCtD
Fingolimod—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000486	0.00136	CcSEcCtD
Fingolimod—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000486	0.00136	CcSEcCtD
Fingolimod—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00048	0.00134	CcSEcCtD
Fingolimod—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00048	0.00134	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000475	0.00222	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000475	0.00222	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000469	0.0022	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000469	0.0022	CbGpPWpGaD
Fingolimod—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000468	0.0013	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000468	0.00219	CbGpPWpGaD
Fingolimod—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000464	0.00129	CcSEcCtD
Fingolimod—Headache—Vincristine—peripheral nervous system neoplasm	0.000462	0.00129	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—ENO2—peripheral nervous system neoplasm	0.00046	0.00216	CbGpPWpGaD
Fingolimod—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000456	0.00127	CcSEcCtD
Fingolimod—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000454	0.00553	CbGeAlD
Fingolimod—S1PR3—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000452	0.00212	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000452	0.00212	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000452	0.00212	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—BCHE—peripheral nervous system neoplasm	0.000451	0.00211	CbGpPWpGaD
Fingolimod—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000447	0.00124	CcSEcCtD
Fingolimod—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000444	0.00124	CcSEcCtD
Fingolimod—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000441	0.00123	CcSEcCtD
Fingolimod—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000438	0.00122	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000431	0.00202	CbGpPWpGaD
Fingolimod—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000431	0.00202	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.00043	0.00201	CbGpPWpGaD
Fingolimod—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000429	0.0012	CcSEcCtD
Fingolimod—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000429	0.0012	CcSEcCtD
Fingolimod—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000428	0.00119	CcSEcCtD
Fingolimod—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000425	0.00118	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—TH—peripheral nervous system neoplasm	0.000424	0.00198	CbGpPWpGaD
Fingolimod—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000423	0.00118	CcSEcCtD
Fingolimod—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000417	0.00116	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000414	0.00194	CbGpPWpGaD
Fingolimod—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000413	0.00115	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.00041	0.00192	CbGpPWpGaD
Fingolimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.00041	0.00192	CbGpPWpGaD
Fingolimod—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000409	0.00114	CcSEcCtD
Fingolimod—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.00114	CcSEcCtD
Fingolimod—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000405	0.00113	CcSEcCtD
Fingolimod—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000397	0.00111	CcSEcCtD
Fingolimod—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000396	0.0011	CcSEcCtD
Fingolimod—SPHK1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000396	0.00185	CbGpPWpGaD
Fingolimod—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000395	0.0011	CcSEcCtD
Fingolimod—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.0011	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000389	0.00182	CbGpPWpGaD
Fingolimod—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000387	0.00108	CcSEcCtD
Fingolimod—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.00107	CcSEcCtD
Fingolimod—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000382	0.00107	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000382	0.00179	CbGpPWpGaD
Fingolimod—Headache—Etoposide—peripheral nervous system neoplasm	0.000375	0.00104	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000371	0.00174	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000371	0.00174	CbGpPWpGaD
Fingolimod—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000368	0.00102	CcSEcCtD
Fingolimod—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000368	0.00102	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—TH—peripheral nervous system neoplasm	0.000366	0.00171	CbGpPWpGaD
Fingolimod—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000363	0.00101	CcSEcCtD
Fingolimod—Cough—Epirubicin—peripheral nervous system neoplasm	0.000358	0.000999	CcSEcCtD
Fingolimod—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.000998	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000357	0.00167	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000357	0.00167	CbGpPWpGaD
Fingolimod—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000355	0.000988	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000347	0.000968	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—GNAS—peripheral nervous system neoplasm	0.000346	0.00162	CbGpPWpGaD
Fingolimod—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.000948	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000339	0.00159	CbGpPWpGaD
Fingolimod—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000936	CcSEcCtD
Fingolimod—SPHK1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000334	0.00156	CbGpPWpGaD
Fingolimod—Infection—Epirubicin—peripheral nervous system neoplasm	0.000333	0.000928	CcSEcCtD
Fingolimod—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000924	CcSEcCtD
Fingolimod—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000916	CcSEcCtD
Fingolimod—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.000914	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000326	0.00153	CbGpPWpGaD
Fingolimod—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000907	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000324	0.00152	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000895	CcSEcCtD
Fingolimod—SPHK1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000319	0.00149	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000317	0.00148	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—TH—peripheral nervous system neoplasm	0.000314	0.00147	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000314	0.00147	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000314	0.00147	CbGpPWpGaD
Fingolimod—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000873	CcSEcCtD
Fingolimod—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000859	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000305	0.00143	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000305	0.00143	CbGpPWpGaD
Fingolimod—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000848	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000302	0.00142	CbGpPWpGaD
Fingolimod—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000839	CcSEcCtD
Fingolimod—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000839	CcSEcCtD
Fingolimod—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000833	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—GNAS—peripheral nervous system neoplasm	0.000299	0.0014	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000293	0.00137	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000291	0.00136	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000291	0.00136	CbGpPWpGaD
Fingolimod—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.000808	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000806	CcSEcCtD
Fingolimod—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000805	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000287	0.00134	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000285	0.00134	CbGpPWpGaD
Fingolimod—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000776	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000277	0.0013	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000277	0.0013	CbGpPWpGaD
Fingolimod—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.00077	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.000746	CcSEcCtD
Fingolimod—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000745	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000267	0.00125	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000267	0.00125	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000264	0.00124	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000257	0.0012	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000252	0.00118	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000245	0.00115	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000242	0.00113	CbGpPWpGaD
Fingolimod—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00024	0.00067	CcSEcCtD
Fingolimod—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000661	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000234	0.00109	CbGpPWpGaD
Fingolimod—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000639	CcSEcCtD
Fingolimod—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.00062	CcSEcCtD
Fingolimod—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000618	CcSEcCtD
Fingolimod—CYP2E1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00022	0.00103	CbGpPWpGaD
Fingolimod—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000611	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000215	0.001	CbGpPWpGaD
Fingolimod—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000591	CcSEcCtD
Fingolimod—Headache—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000585	CcSEcCtD
Fingolimod—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000571	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000196	0.000918	CbGpPWpGaD
Fingolimod—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000541	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000193	0.000902	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000189	0.000884	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000189	0.000884	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000186	0.000869	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000186	0.000869	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000171	0.000803	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000168	0.000789	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000156	0.000729	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000152	0.000713	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000149	0.000698	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000148	0.000694	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000147	0.000686	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000147	0.000686	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000144	0.000672	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.00014	0.000653	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000138	0.000647	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000138	0.000647	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000138	0.000647	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000134	0.000629	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000134	0.000629	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000133	0.000623	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000133	0.000623	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000133	0.000623	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000127	0.000593	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000125	0.000587	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000122	0.000571	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000122	0.000571	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000122	0.000571	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000121	0.000566	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000118	0.000552	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000116	0.000543	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000112	0.000522	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000112	0.000522	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000111	0.000519	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000108	0.000505	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GNS—peripheral nervous system neoplasm	0.000107	0.000502	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000107	0.000501	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000105	0.000493	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000104	0.000486	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000104	0.000486	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NME1—peripheral nervous system neoplasm	0.000103	0.000481	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000102	0.000477	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000101	0.000474	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—COX2—peripheral nervous system neoplasm	9.89e-05	0.000463	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.44e-05	0.000442	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—AKT1—peripheral nervous system neoplasm	9.34e-05	0.000437	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.96e-05	0.00042	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.86e-05	0.000415	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.53e-05	0.000399	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.53e-05	0.000399	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.48e-05	0.000397	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.35e-05	0.000391	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.16e-05	0.000382	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.16e-05	0.000382	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—AKT1—peripheral nervous system neoplasm	8.06e-05	0.000377	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.75e-05	0.000363	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	7.61e-05	0.000356	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.49e-05	0.00035	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.41e-05	0.000347	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	7.29e-05	0.000341	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.21e-05	0.000337	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.21e-05	0.000337	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	7.02e-05	0.000329	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—AKT1—peripheral nervous system neoplasm	6.93e-05	0.000324	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.88e-05	0.000322	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.86e-05	0.000321	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.56e-05	0.000307	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.54e-05	0.000306	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ENO2—peripheral nervous system neoplasm	6.49e-05	0.000304	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.79e-05	0.000271	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	5.49e-05	0.000257	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.24e-05	0.000245	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	5.16e-05	0.000242	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	4.97e-05	0.000233	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	4.77e-05	0.000223	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	4.61e-05	0.000216	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	4.59e-05	0.000215	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	4.21e-05	0.000197	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	4.13e-05	0.000193	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	3.89e-05	0.000182	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.71e-05	0.000174	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	3.66e-05	0.000171	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	3.01e-05	0.000141	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	2.99e-05	0.00014	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	2.93e-05	0.000137	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.55e-05	0.000119	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.43e-05	0.000114	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	2.39e-05	0.000112	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.95e-05	9.15e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.92e-05	8.98e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	1.14e-05	5.32e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	8.07e-06	3.78e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	5.27e-06	2.47e-05	CbGpPWpGaD
